HealthQuill GEne therapy
An 18-month-old baby girl, Opal Sandy, who was born deaf got back her hearing ability after gene therapy — the youngest child to receive such treatment.
Drugs Health Pharma

Deaf 18-month girl gets back hearing ability after gene therapy

HQ Team May 15, 2024: An 18-month-old baby girl, Opal Sandy, who was born deaf got back her hearing ability after gene therapy.

Read More
Drugs Health Medical

Gene therapy restores hearing in children with inherited deafness

Bharti Jayshankar January 25, 2024: A new gene therapy has demonstrated remarkable success in treating inherited deafness. Two separate studies, one conducted by.

Read More
Voyager Therapeutics, Inc., will receive an upfront payment of $100 million from Switzerland-based Novartis AG to develop gene therapies for two genetic disorders.
Drugs Health Pharma

Novartis to pay $100m upfront to Voyager for gene therapies

HQ Team January 3, 2023: Voyager Therapeutics, Inc., will receive an upfront payment of $100 million from Switzerland-based Novartis AG to develop gene.

Read More
The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for the past 30 years, according to US scientists.
Drugs Health Medical

Opinion: Sickle Cell Disease and gene therapy

By K. Leelamoni December 19, 2023: Recent reports about the FDA’s approval of gene therapy to treat Sickle Cell Anemia mark a major.

Read More
Health Medical Pharma

Gene to treat chronic muscle disorders found

HQ team November 13, 2023: Researchers at the University of California, Irvine, have identified a gene that helps in muscle repair during regeneration..

Read More
The receptor of Oxytocin, a hormone considered essential to forming social bonds, may not play the role that scientists have assigned it for the past 30 years, according to US scientists.
Drugs Health Medical Pharma

Gene therapy cure for sickle cell awaits advisory approval

HQ Team October 28, 2023: Advisers to the Food and Drug Administration (FDA) are set to review a gene therapy for sickle cell.

Read More
Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for gene therapy projects.
Drugs Health Pharma

Alexion, Pfizer sign $1 billion accord for genomic medicines

HQ Team July 29, 2023: Alexion, AstraZeneca Rare Disease, an arm of AstraZeneca group, has signed a $1 billion pact with Pfizer for.

Read More
Researchers found a genetic variant that increases the severity of multiple sclerosis (MS) and may pave the way for a new generation of treatments to prevent disease degeneration.
Drugs Health Pharma

Gene variant discovery may trigger new treatments for multiple sclerosis

HQ Team July 5, 2023: Researchers found a genetic variant that increases the severity of multiple sclerosis (MS) and may pave the way.

Read More
Pfizer Inc. announced that USFDA has accepted its biologics license application for treating bleeding disorders in adults through gene therapy.
Drugs Medical Pharma

FDA, EMA accept Pfizer’s BLP application for hemophilia therapy

HQ Team June 26, 2023: Pfizer Inc. announced that USFDA has accepted its biologics license application for treating bleeding disorders in adults through.

Read More
gene therapy
Drugs Medical

FDA approves gene therapy for treatment of high-risk bladder cancer

The FDA approved Adstiladrin (nadofaragene firadenovec-vncg), a non-replicating adenoviral vector-based gene therapy for the treatment of high-risk bladder cancer.

Read More
X